News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,138 Results
Type
Article (44518)
Company Profile (298)
Press Release (684312)
Multimedia
Podcasts (84)
Webinars (17)
Section
Business (206004)
Career Advice (2037)
Deals (35674)
Drug Delivery (113)
Drug Development (81994)
Employer Resources (174)
FDA (16514)
Job Trends (15037)
News (348588)
Policy (32975)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2648)
Accelerated approval (33)
Adcomms (27)
Allergies (138)
Alliances (50061)
ALS (172)
Alzheimer's disease (1668)
Antibody-drug conjugate (ADC) (307)
Approvals (16759)
Artificial intelligence (509)
Autoimmune disease (148)
Automation (37)
Bankruptcy (364)
Best Places to Work (11723)
BIOSECURE Act (21)
Biosimilars (187)
Biotechnology (201)
Bladder cancer (158)
Brain cancer (58)
Breast cancer (635)
Cancer (4787)
Cardiovascular disease (398)
Career advice (1718)
Career pathing (35)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (745)
Cervical cancer (36)
Clinical research (69898)
Collaboration (1693)
Company closure (4)
Compensation (1157)
Complete response letters (56)
COVID-19 (2745)
CRISPR (91)
C-suite (831)
Cystic fibrosis (145)
Data (6193)
Decentralized trials (2)
Denatured (26)
Depression (131)
Diabetes (498)
Diagnostics (6744)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (246)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (230)
Earnings (90344)
Editorial (55)
Employer branding (21)
Employer resources (152)
Events (118166)
Executive appointments (966)
FDA (19605)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1460)
Gene editing (205)
Generative AI (43)
Gene therapy (616)
GLP-1 (970)
Government (4688)
Grass and pollen (7)
Guidances (383)
Healthcare (18988)
HIV (57)
Huntington's disease (46)
IgA nephropathy (81)
Immunology and inflammation (246)
Immuno-oncology (54)
Indications (104)
Infectious disease (3005)
Inflammatory bowel disease (189)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (319)
IPO (16702)
IRA (49)
Job creations (3665)
Job search strategy (1438)
JPM (58)
Kidney cancer (15)
Labor market (83)
Layoffs (555)
Leadership (30)
Legal (8003)
Liver cancer (93)
Longevity (14)
Lung cancer (646)
Lymphoma (373)
Machine learning (42)
Management (59)
Manufacturing (778)
MASH (162)
Medical device (13768)
Medtech (13820)
Mergers & acquisitions (20029)
Metabolic disorders (1262)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (312)
Neuropsychiatric disorders (87)
Neuroscience (2894)
Neurotech (1)
NextGen: Class of 2026 (6592)
Non-profit (4578)
Now hiring (65)
Obesity (593)
Opinion (265)
Ovarian cancer (164)
Pain (199)
Pancreatic cancer (224)
Parkinson's disease (280)
Partnered (33)
Patents (490)
Patient recruitment (475)
Peanut (55)
People (59251)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21853)
Phase 2 (30749)
Phase 3 (22900)
Pipeline (5129)
Policy (281)
Postmarket research (2585)
Preclinical (9319)
Press Release (67)
Prostate cancer (235)
Psychedelics (48)
Radiopharmaceuticals (278)
Rare diseases (861)
Real estate (5994)
Recruiting (69)
Regulatory (24629)
Reports (51)
Research institute (2486)
Resumes & cover letters (354)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (147)
Series A (242)
Series B (187)
Service/supplier (12)
Sickle cell disease (100)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (41)
Startups (3666)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (85)
The Weekly (56)
Vaccines (999)
Venture capital (88)
Weight loss (381)
Women's health (87)
Worklife (18)
Date
Today (92)
Last 7 days (570)
Last 30 days (2051)
Last 365 days (30026)
2026 (2931)
2025 (30380)
2024 (35480)
2023 (40318)
2022 (51527)
2021 (56037)
2020 (54397)
2019 (46868)
2018 (35298)
2017 (32457)
2016 (31917)
2015 (37926)
2014 (31652)
2013 (26838)
2012 (29017)
2011 (29667)
2010 (27744)
Location
Africa (762)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39700)
Australia (6530)
California (11235)
Canada (3259)
China (1090)
Colorado (472)
Connecticut (478)
Delaware (332)
Europe (86087)
Florida (1664)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (853)
India (62)
Indiana (518)
Iowa (23)
Japan (421)
Kansas (125)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1379)
Massachusetts (8079)
Michigan (319)
Minnesota (623)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (79)
New Jersey (2974)
New Mexico (29)
New York (2958)
North Carolina (1453)
North Dakota (9)
Northern California (5474)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2272)
Puerto Rico (22)
Rhode Island (47)
South America (1129)
South Carolina (65)
South Dakota (1)
Southern California (4365)
Tennessee (172)
Texas (1728)
United States (39838)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (937)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
729,138 Results for "fulgent genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
December 23, 2025
·
10 min read
Press Releases
Fulgent to Participate in Upcoming Conferences - November 7, 2025
November 10, 2025
·
1 min read
Press Releases
Fulgent Reports Third Quarter 2025 Financial Results
November 10, 2025
·
15 min read
Press Releases
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
October 21, 2025
·
7 min read
Press Releases
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
October 16, 2025
·
1 min read
Press Releases
Fulgent Reports Second Quarter 2025 Financial Results
August 1, 2025
·
14 min read
Business
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024.
April 11, 2024
·
1 min read
Press Releases
Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025
July 10, 2025
·
1 min read
Business
Fulgent Reports First Quarter 2024 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31, 2024.
May 3, 2024
·
13 min read
Business
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Fulgent Genetics, Inc. today announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February 28, 2024.
February 13, 2024
·
1 min read
1 of 72,914
Next
